Sinapis Pharma's Bridge Round

Sinapis Pharma raised a round of funding on May 06, 2010.

Sinapis Pharma is a discovery stage biotechnology company that has identified and has patents-pending for a new use and route of administration for its lead compound, Methamphetamine, an FDA-approved …

Articles about Sinapis Pharma's Bridge Round: